Nanocarry
Tel Aviv, Israel · Founded 2021
- Headquarters
- Tel Aviv
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- nanocarry.com
- Last Round
- SeedJan 2025
- Rounds
- 3
Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.
About
Nanocarry develops brain therapeutics by combining biological approaches with nanoparticles, allowing biologics to cross the blood-brain barrier. Its approach aims to create first-in-class treatments for neuro-oncology indications and diseases of the central nervous system by enabling biological therapeutics to reach the brain.
Summary
Nanocarry is a Biotech company based in Tel Aviv, Israel, founded in 2021. Its most recent funding was a Seed round in Jan 2025. Investors include NFX.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
2025 (est.)
Sign up to see all 3 events
Funding: Pre-Seed through Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nanocarry"><img src="https://indexed.vc/api/badge/company/nanocarry" alt="Nanocarry on Indexed.vc" width="260" height="76" /></a>